性饮食:一种潜在的辅助治疗物质使用障碍
Deshenyue Kong1,2,3, Jia-Xue Sun2,3, Ji-Qun Yang4
1General Hospital of Eastern Theater Command, Nanjing, China.
Frontiers in nutrition
|August 14, 2023
概括
性饮食 (KD) 可以通过改善新陈代谢和减少戒断症状来帮助治疗物质使用障碍 (SUD). 虽然有希望,但由于潜在的副作用,需要更多的研究.
科学领域:
- 神经科学是一个神经科学.
- 代谢障碍 代谢障碍 代谢障碍
- 饮食疗法是一种饮食疗法.
背景情况:
- 药物使用障碍 (SUD) 给健康带来了重大挑战,推动了寻找新疗法的研究.
- 素饮食 (KD),以神经学益处而闻名,正在探索其在管理SUD方面的潜力.
- SUD与代谢失调,神经炎症,氧化应激和肠道失调有关,这是KD可能干预的领域.
研究的目的:
- 审查素饮食 (KD) 对物质使用障碍 (SUD) 的潜在治疗效果.
- 探索KD如何解决与SUD相关的代谢和神经系统障碍.
- 突出KD作为SUD的潜在补充治疗策略.
主要方法:
- 对调查KD及其对神经和代谢条件的影响研究的文献综述.
- 分析KD可能影响SUD的拟议机制,包括代谢和神经可塑性.
- 检查SUD的生理变化,如线粒体功能障碍和炎症,与KD干预相关.
主要成果:
- 通过增强代谢,KD可以改善酒精使用障碍中的葡萄糖代谢障碍,从而可能减少戒断.
- 通过KD减少碳水化合物摄入量可以抵消SUD中与糖摄入相关的交叉敏感化.
- 肯德里显示有潜力扭转与SUD相关的异常,如线粒体损伤,氧化应激,炎症和肠道失调.
结论:
- 通过解决潜在的生理异常,KD为SUD提供了一个有希望的治疗途径.
- 需要进一步的研究来验证KD的疗效,并管理其在SUD治疗中的潜在副作用.
- 肯德基调节新陈代谢和神经炎症的能力为管理物质使用障碍提供了一种新的方法.
更多相关视频
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.2K
07:05Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
8.9K
相关概念视频
Substance Use Disorders Affecting Sleep
196
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
196
Drug Abuse and Addiction: Pharmacological Phenomena
515
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
515
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Drug Dependence
1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
Diabetes: Management and Pharmacotherapy
311
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
311
